Industry News
Gene research to improve development of new drugs
Researchers at the ANU’s Medical Genome Centre are researching a powerful new technique for developing drugs.
[ + ]Light science aids life science
A $1.6 million research centre in Queensland will put advanced photonics tools like laser tweezers in the hands of life science researchers. [ + ]
Tumour barcode spells hope for better cancer diagnosis
Cancer patients could face improved diagnoses and survival rates with the development of a tumour barcode. [ + ]
Optiscan counts the cash in wake of Pentax deal
OPTISCAN has banked its first installment from the $AUD19.6 million Pentax endomicroscope deal announced last week. [ + ]
WA Science Council recommends research and development shake-up
Geoff Gallop, Western Australia Premier, has received the first report from his Science Council.
[ + ]Clone company bullish in Asian market
Two cloned calves of a top breeding bull are being sold in Asia by Australian breeder RAB for almost $400,000 each. [ + ]
Microbes cop a double whammy with new drug
Perth biotech Chemeq Ltd (ASX: CMQ) has developed a new kind of antimicrobial that may revolutionise agriculture and reduce the development of drug-resistant bacteria. [ + ]
GM antibody technology a shot in the arm for Agen
Agen Biomedical is putting an improved version of its 20-year-old cash cow out to graze in fresh pastures. [ + ]
New drug chews the fat for Metabolic
Melbourne-based Metabolic Pharmaceuticals is claiming early phase clinical trial success with its new obesity drug. [ + ]
London calling for local biotechs
The London Stock Exchange is spruiking for business from Australian biotech companies who want to transmute their intellectual property into financial capital. [ + ]
Prima in high-level licensing talks
Prima BioMed has commenced preliminary talks with several major drug companies over potential licensing options for its new anti-inflammatory compound,VIB 153. [ + ]
Our clones are safe, says company
Melbourne-based biotech Clone International has distanced itself from a new Japanese study that casts doubt on the safety and usefulness of a cloning technique. [ + ]
The chips are down 'almost' for IBM Blue Gene project
One of IT giant IBM's key researchers was in Australia this week to tout the progress of the company's $US100 million Blue Gene project. [ + ]
Research and business meet on new Cerylid board
Cerylid Biosciences has appointed a scientific advisory board made up of big players from the biotech and pharmaceutical sectors. [ + ]
IMB speeds protein research with new tool
A new proteomics research tool that looks like a bar fridge and costs a cool $500,000 is giving a handy competitive edge to Queensland's Institute of Molecular Bioscience. [ + ]
